S. Kipriyanov

发表

Covalent dimerization of camelidae anti-human TNF-alpha single domain antibodies by the constant kappa light chain domain improves neutralizing activity.

J. Scheller, U. Conrad, D. Floss, 2010, Biotechnology and bioengineering.

Generation of bispecific and tandem diabodies.

S. Kipriyanov, 2009, Methods in molecular biology.

Xenografts with a CD 3 × CD 19 Diabody and Treatment of Human B Cell Lymphoma

M. Little, S. Kipriyanov, G. Strauss, 2000 .

Immunosuppressive properties of anti-CD3 single-chain Fv and diabody.

M. Little, S. Kipriyanov, U. Reusch, 2004, Journal of immunological methods.

Generation and production of engineered antibodies

S. Kipriyanov, F. Gall, Sergey M. Kipriyanov, 2004, Molecular biotechnology.

Model structure of the immunodominant surface antigen of Eimeria tenella identified as a target for sporozoite-neutralizing monoclonal antibody

Martin Giersberg, S. Kipriyanov, H. Mock, 2009, Parasitology Research.

Antibody expressing pea seeds as fodder for prevention of gastrointestinal parasitic infections in chickens

Martin Giersberg, S. Kipriyanov, I. Saalbach, 2009, BMC biotechnology.

Lymphomaa Preclinical Model of Non-Hodgkin's CD19 × CD3 and CD19 × CD16 Diabodies in Synergistic Antitumor Effect of Bispecific

M. Little, S. Kipriyanov, G. Moldenhauer, 2002 .

Coomassie Blue-stained SDS / Polyacrylamide Gel of Purified bSCCD 19 xCD 3 plug

S. Kipriyanov, J. Dejonge, J. D. Jonge, 2017 .

High-level periplasmic expression and purification of scFvs.

S. Kipriyanov, 2009, Methods in molecular biology.

Effect of tetravalent bispecific CD19×CD3 recombinant antibody construct and CD28 costimulation on lysis of malignant B cells from patients with chronic lymphocytic leukemia by autologous T cells

M. Little, A. Ho, S. Kipriyanov, 2004, International journal of cancer.

Generation and characterization of bispecific tandem diabodies for tumor therapy.

S. Kipriyanov, 2003, Methods in molecular biology.

Bacterial Expression, Purification, and Characterization of Single-Chain Antibodies

S. Kipriyanov, 2002 .

Bispecific CD3 × CD19 diabody for T cell‐mediated lysis of malignant human B cells

M. Little, S. Kipriyanov, G. Strauss, 1998 .

Apoptosis of a human melanoma cell line specifically induced by membrane-bound single-chain antibodies.

M. Little, S. Kipriyanov, H. Rode, 1999, Journal of immunology.

T Cells Xenografts with a CD3 × CD19 Diabody and Treatment of Human B Cell Lymphoma

M. Little, S. Kipriyanov, G. Strauss, 2000 .

Effect of linker sequences between the antibody variable domains on the formation, stability and biological activity of a bispecific tandem diabody.

M. Little, S. Kipriyanov, U. Reusch, 2004, Protein engineering, design & selection : PEDS.

The novel bispecific diabody αCD40/αCD28 strengthens leukaemic dendritic cell‐induced T‐cell reactivity

Q. Waisfisz, T. D. de Gruijl, G. Ossenkoppele, 2008, British journal of haematology.

The Novel Bispecific Diabody αCD40/αCD28 Strengthens Leukemic Dendritic Cell Induced T Cell Reactivity.

Q. Waisfisz, G. Ossenkoppele, S. Kipriyanov, 2006 .

Recent advances in the generation of bispecific antibodies for tumor immunotherapy.

S. Kipriyanov, F. Le Gall, 2004, Current opinion in drug discovery & development.

Generation of bispecific and tandem diabodies.

S. Kipriyanov, 2002, Methods in molecular biology.

Bacterial expression and refolding of single-chain Fv fragments with C-terminal cysteines

M. Little, F. Breitling, S. Dübel, 1995, Cell Biophysics.

Generation of recombinant antibodies

M. Little, S. Kipriyanov, M Little, 1999, Molecular biotechnology.

Single-Chain Antibodies Specifically Induced by Membrane-Bound Apoptosis of a Human Melanoma Cell Line

M. Little, S. Kipriyanov, H. Rode, 1999 .

Characterization of the epitope recognized by a monoclonal antibody directed against the largest subunit of Drosophila RNA polymerase II.

F. Breitling, S. Dübel, R. Kontermann, 1995, Biological chemistry Hoppe-Seyler.

Effect of domain order on the activity of bacterially produced bispecific single-chain Fv antibodies.

M. Little, M. Braunagel, S. Kipriyanov, 2003, Journal of molecular biology.

Generation of antibody molecules through antibody engineering.

S. Kipriyanov, 2003, Methods in molecular biology.

Treatment of Human B Cell Lymphoma Xenografts with a CD3 × CD19 Diabody and T Cells1

M. Little, S. Kipriyanov, G. Strauss, 2000, The Journal of Immunology.

Synergistic Antitumor Effect of Bispecific CD19 × CD3 and CD19 × CD16 Diabodies in a Preclinical Model of Non-Hodgkin’s Lymphoma1

Gerhard Moldenhauer, M. Little, S. Kipriyanov, 2002, The Journal of Immunology.

Combined effect of recombinant CD19×CD16 diabody and thalidomide in a preclinical model of human B cell lymphoma

H. Goldschmidt, M. Little, A. Benner, 2004, Anti-cancer drugs.

Recombinant antibodies in infectious disease

S. Kipriyanov, Sergey M Kipriyanov, 2004 .

Xenotransplantated Human Hodgkin's Tumors A Bispecific Diabody That Mediates Natural Killer Cell Cytotoxicity Against

M. Pfreundschuh, M. Little, S. Kipriyanov, 2013 .

Di‐, tri‐ and tetrameric single chain Fv antibody fragments against human CD19: effect of valency on cell binding

M. Little, S. Kipriyanov, S. Kipriyanov, 1999, FEBS letters.

Two amino acid mutations in an anti-human CD3 single chain Fv antibody fragment that affect the yield on bacterial secretion but not the affinity.

M. Little, S. Kipriyanov, S. Kipriyanov, 1997, Protein engineering.

Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics.

M. Little, S. Kipriyanov, C. W. von der Lieth, 1999, Journal of molecular biology.

The novel bispecific diabody αCD40/αCD28 strengthens leukaemic dendritic cell‐induced T‐cell reactivity

Q. Waisfisz, T. D. de Gruijl, G. Ossenkoppele, 2008, British journal of haematology.

High-level periplasmic expression and purification of scFvs.

S. Kipriyanov, 2009, Methods in molecular biology.